Novo Nordisk is suing Eli Lilly over ads it says mislead consumers on weight loss drug efficacy Jul 21, 2026 · Cris Tolomia Novo says Lilly's TV and social media campaigns cite outdated trial data to make Zepbound and Mounjaro look more effective than rival injections Read more »
.jpg?branch=production)
